NCT02965638View on ClinicalTrials.gov

Trial of Maternal Oxygen for Fetal Left Heart Hypoplasia

NAActive, not recruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

July 31, 2027

Study Completion Date

July 31, 2027

Conditions
Fetal Left Heart Hypoplasia
Interventions
OTHER

Oxygen

The intervention arm (Oxygen Group) will receive oxygen via nasal cannula at a rate of 4L of FiO2 93-100% from an oxygen concentrator up to 24 hours daily

Trial Locations (1)

77030

Texas Children's Hospital, Houston

All Listed Sponsors
lead

Shaine Morris

OTHER

NCT02965638 - Trial of Maternal Oxygen for Fetal Left Heart Hypoplasia | Biotech Hunter | Biotech Hunter